Mutant p53 proteins: between loss and gain of function

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Cancer development involves gene activation and tumor suppressor gene inactivation.
• The p53 gene, a critical tumor suppressor, is frequently inactivated by missense mutations in human cancers.
• Mutant p53 proteins acquire oncogenic functions, promoting tumor insurgence, maintenance, and metastasis.

Purpose of the Study:

• To review the molecular mechanisms of gain-of-function mutations in human tumor-derived p53.
• To analyze the impact of mutant p53 on chemoresistance and prognosis in human cancers, particularly head and neck cancers.
• To discuss therapeutic strategies targeting mutant p53 proteins.

Main Methods:

• Literature review focusing on molecular mechanisms of p53 mutations.
• Analysis of studies investigating p53 mutant protein function.
• Examination of clinical data on chemoresistance and prognosis related to p53 mutations.

Main Results:

• Mutant p53 proteins exhibit gain-of-function activities, contributing to oncogenesis.
• p53 mutations are associated with altered chemoresistance and poorer prognosis in various cancers.
• Head and neck cancers show a significant impact of mutant p53 on clinical outcomes.

Conclusions:

• Understanding mutant p53 gain-of-function mechanisms is crucial for cancer therapy.
• Targeting mutant p53 offers a promising therapeutic avenue for cancer treatment.
• Further research into manipulating mutant p53 holds potential for improving patient outcomes.